Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Norman Wolmark, MD
NSABP Foundation Inc
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Uf Health Davis Cancer Pavilion & Shands Medical Plaza
Gainesville, Florida, United States
- Cancer Care Specialists of Central Illinois
Decatur, Illinois, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Crossroads Cancer Center
Effingham, Illinois, United States
- Cancer Care Specialists of Central Il-Swansea
Swansea, Illinois, United States
- University of Michigan
Ann Arbor, Michigan, United States
- University of Michigan-Oncology
Ann Arbor, Michigan, United States
- University of Michigan-Brighton Center for Specialty Care
Brighton, Michigan, United States
- Healthpartners Riverside Clinic
Minneapolis, Minnesota, United States
- Hennepin County Medical Center
Minneapolis, Minnesota, United States
- Minnesota Oncology-Minneapolis
Minneapolis, Minnesota, United States
- Hubert H. Humphrey Cancer Center
Robbinsdale, Minnesota, United States
- Metro Minnesota Community Oncology Research Consortium-Mmcorc
Saint Louis Park, Minnesota, United States
- Thomas Jefferson University Hospital-Sidney Kimmel Cancer Network
Philadelphia, Pennsylvania, United States
- Upmc Hillman Cancer Center
Pittsburgh, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 May 2019
- Primary completion
- 31 Oct 2021
- Completion
- 30 Nov 2022
- Last update posted
- 10 Jun 2022
- Registered enrollment
- 33
- Registry id
- NCT03626922
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.